Advertisement SurgiQuest wins FDA clearance for AirSeal DPS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

SurgiQuest wins FDA clearance for AirSeal DPS

SurgiQuest, a developer and manufacturer of minimally invasive surgery devices, has announced that its AirSeal Dynamic Pressure System has received the FDA 510(k) approval for smoke evacuation.

According to the company, the AirSeal Dynamic Pressure System (DPS) provides access by eliminating mechanical valves from the cannula and facilitating the introduction of multiple laparoscopic instruments through a single AirSeal cannula. The AirSeal DPS continuously re-circulates and filters CO2 used to insufflate the abdomen during laparoscopic surgical procedures.

Additionally, the AirSeal DPS system provides a proprietary clinical advantage through its ability to simultaneously monitor the insufflator to maintain (pneumoperitoneum) pressure inside the abdomen, the company said.

Kurt Azarbarzin, founder and CEO of SurgiQuest, said: “Our mission has been to improve access and visualization during laparoscopic procedures. One of the key features of the AirSeal DPS technology is the ability to automatically remove smoke during laparoscopic procedures providing the surgeon unencumbered access while improving visualization.”